AzTrials
AzTrials

StrokeNCT06764290

Neural Changes in Stroke Patients During Challenging Walking Tasks.

An observational study of Stroke, run by Nanjing Medical University at 2 sites in China.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

For stroke patients, a challenging, unfamiliar, and more difficult task may increase the likelihood of brain activation to stimulate recovery. Pedal walking and walking with eyes-covered are both difficult and challenging tasks for stroke patients. Read more about this study

Who is it for?
Ages 18 to 70 years
Conditions the study is for
Stroke
What is being tested?
pedal walking and visual occlusion
How many people
60 participants
Where
2 sitesChina
Study dates
1 Apr 2024to 28 Feb 2025
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 70 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Stroke patients, including outpatients and inpatients.

Who may be able to join

  • First-time occurrence of stroke confirmed by computed tomography or magnetic resonance imagingClinical diagnosis of stroke
  • Disease duration of more than 14 days, less than 1 year
  • Able to walk independently but with a lingering abnormal gait

Who cannot join

  • Lesions accumulate in the brainstem
  • Lesions accumulate in the cerebellum
  • Impaired vision
  • Severe cognitive impairment

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Jing Zhao, master contact

+8618817892579

18817892579@163.com

China2 sites, 2 recruiting
  • Geriatric Hospital of Nanjing Medical University, 269 Qingmen Street

    Nanjing, Jiangsu, 210000

    Recruiting
  • Geriatric Hospital of Nanjing Medical University

    Nanjing, Jiangsu, 210000

    Qian Zhang, Phd, +86 181 68417672, 2317123547@qq.com

    Recruiting

Other trials in China

About this study

Official title: Neural Mechanism Changes in Stroke Patients During Challenging Environments

For stroke patients, a challenging, unfamiliar, and more difficult task may increase the likelihood of brain activation to stimulate recovery. Pedal walking and walking with eyes-covered are both difficult and challenging tasks for stroke patients. The investigators intend to study the biomechanics and neural mechanisms of challenging pedal walking and walking with eyes covered.

Stroke participants will wear electroencephalogram electrode caps and perform three tasks: walking on a flat surface for 60 seconds, walking on pedal for 60 seconds, and walking with eyes covered for 60 seconds.

Read the detailed description

Stroke participants will wear a 32-lead electroencephalogram electrode cap (Zhentai Technology Company, Xi 'an, China), first walk on a flat ground for 60 seconds, rest for 2 minutes, then walk on the pedal for 60 seconds, rest again for 2 minutes, and walk for 60 seconds with eyes-covered.

Conditions
Stroke
Being tested
pedal walking, visual occlusion
Keywords
Electroencephalography, gait rehablitation, challenging task
Medical subject headings
Stroke

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • pedal walkingOther

    Pedal walking is a challenging walking task that can be used as a form of physical therapy for stroke participants.

  • visual occlusionOther

    Walking with eyes-covered is a challenging walking task that can be used as a form of physical therapy for stroke participants.

Study groups in NCT06764290
Study groupRoleWhat they receive
stroke participantsStroke participants with residual abnormal gait.
Receives: Other: pedal walking; Other: visual occlusion

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Weight Phase Lag Index

    The Weighted Phase Lag Index (WPLI) is a measure used to quantify phase synchronization in electrophysiological data.Continuously measure the connectivity of the coupling of neural oscillatory activity in the brain, while being statistically more powerful in detecting changes in signal phase synchronization.The WPLI ranges from 0 to 1, with 0 indicating no phase synchronization and 1 indicating complete phase synchronization.

    Measured: The study was an observational cross-sectional study with data collected at the same time as the trial was being conducted, so the duration was 60 seconds

  2. Relative power

    The electroencephalogram signal in the time domain is converted into the relevant information in the frequency domain, the frequency bands are divided, and the relative power results of each channel in each frequency band are derived. Among them, delta:1-4Hz, theta:4-8Hz, alpha:8-15Hz, beta:15-30Hz, gamma:30-45Hz.

    Measured: The study was an observational cross-sectional study with data collected at the same time as the trial was being conducted, so the duration was 60 seconds

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Jan 2025
  2. Study start1 Apr 2024
  3. Primary completion30 Jan 2025 (estimated)
  4. Study completion28 Feb 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Cross-sectional
Enrolment
60 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06764290
Sponsor's protocol ID
2024018-1
Status last verified
Jan 2025
First submitted
10 Apr 2024
Last updated
8 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: all IPD that underlie results in a publication.

Publications

  • Krakauer JW. Motor learning: its relevance to stroke recovery and neurorehabilitation. Curr Opin Neurol. 2006 Feb;19(1):84-90. doi: 10.1097/01.wco.0000200544.29915.cc.

    PubMed 16415682
  • Fettrow T, Hupfeld K, Tays G, Clark DJ, Reuter-Lorenz PA, Seidler RD. Brain activity during walking in older adults: Implications for compensatory versus dysfunctional accounts. Neurobiol Aging. 2021 Sep;105:349-364. doi: 10.1016/j.neurobiolaging.2021.05.015. Epub 2021 May 31.

    PubMed 34182403
  • Kulkarni A, Cui C, Rietdyk S, Ambike S. Humans prioritize walking efficiency or walking stability based on environmental risk. PLoS One. 2023 Apr 7;18(4):e0284278. doi: 10.1371/journal.pone.0284278. eCollection 2023.

    PubMed 37027387

Questions about this trial

What is this clinical trial studying?

An observational study of Stroke, run by Nanjing Medical University at 2 sites in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 8 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Jing Zhao, master (+8618817892579, 18817892579@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Weight Phase Lag Index (time frame: The study was an observational cross-sectional study with data collected at the same time as the trial was being conducted, so the duration was 60 seconds). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06764290, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Jan 2025.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in
Clinical Trial NCT06764290 | AzTrials